13D Filing: Phase4 Partners Ltd and Albireo Pharma Inc. (ALBO)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of...

Keep Reading →